Stock AnalizClorox Co. CLX
Specialty Chemicals · data as of November 13, 2026
Clorox Co. (CLX) is a consumer discretionary company listed in the US with a market value of about $13.3B. In the twelve months to September 30, 2026 it had revenue of $7.2B and net income of $677M, a net margin of 9.4%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is financial health (1/5).
Key numbers: a P/E of 19.7, a price to free cash flow of 29.3, 5-year revenue growth of 1% a year, a 5-year average ROIC of 17%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 24% below the current price.
Score: 2.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- Positive free cash flow
- Pays a dividend
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $6.7B | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B | $6.7B | $6.2B | $6.1B | $6.0B |
| Net income | $677M | $587M | $810M | $280M | $149M | $462M | $710M | $939M | $820M | $823M | $701M |
| Free cash flow | $453M | $405M | $761M | $483M | $930M | $535M | $945M | $1.3B | $786M | $782M | $634M |
| EPS (diluted) | $5.55 | $4.81 | $6.52 | $2.25 | $1.20 | $3.73 | $5.58 | $7.36 | $6.32 | $6.26 | $5.33 |
| Net margin | 9.4% | 8.7% | 11.4% | 4.0% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% |
| ROIC | — | — | 27.9% | 11.1% | 7.2% | 16.2% | 22.3% | 25.2% | 31.5% | 29.5% | 32.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 16 analysts is $97.00, 11% below the current price; targets range from $74.00 to $142.00; the consensus rating is “Hold”; expected EPS is $5.72 for the fiscal year ending June 30, 2027.
Frequently asked questions
What is Clorox’s P/E ratio?
About 19.7, based on the last twelve months of diluted earnings per share (forward P/E about 19.7).
Is Clorox stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 24% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Clorox pay a dividend?
Yes. The dividend yield is about 4.68%, and it has paid dividends for 10 years in our data.
Is Clorox a good stock to buy?
We do not give buy or sell advice. Clorox scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.